nodes	percent_of_prediction	percent_of_DWPC	metapath
Phosphatidylserine—SCARB1—endothelium—skin cancer	0.0304	0.0488	CbGeAlD
Phosphatidylserine—SCARB1—blood vessel—skin cancer	0.028	0.045	CbGeAlD
Phosphatidylserine—SMPD3—nipple—skin cancer	0.0278	0.0446	CbGeAlD
Phosphatidylserine—PRKCA—skin epidermis—skin cancer	0.0231	0.0371	CbGeAlD
Phosphatidylserine—SCARB1—nipple—skin cancer	0.0203	0.0325	CbGeAlD
Phosphatidylserine—PRKCA—nerve—skin cancer	0.0197	0.0316	CbGeAlD
Phosphatidylserine—DGKD—nipple—skin cancer	0.0191	0.0307	CbGeAlD
Phosphatidylserine—PISD—nipple—skin cancer	0.0188	0.0302	CbGeAlD
Phosphatidylserine—PRKCA—endothelium—skin cancer	0.0168	0.0269	CbGeAlD
Phosphatidylserine—SMPD3—mammalian vulva—skin cancer	0.0162	0.026	CbGeAlD
Phosphatidylserine—PRKCA—blood vessel—skin cancer	0.0155	0.0248	CbGeAlD
Phosphatidylserine—SCARB1—connective tissue—skin cancer	0.0144	0.0231	CbGeAlD
Phosphatidylserine—SCARB1—epithelium—skin cancer	0.0136	0.0219	CbGeAlD
Phosphatidylserine—PTDSS1—lymphoid tissue—skin cancer	0.0136	0.0219	CbGeAlD
Phosphatidylserine—SMPD4—lymphoid tissue—skin cancer	0.0132	0.0211	CbGeAlD
Phosphatidylserine—PTDSS1—female reproductive system—skin cancer	0.0131	0.0211	CbGeAlD
Phosphatidylserine—SCARB1—skin of body—skin cancer	0.013	0.0208	CbGeAlD
Phosphatidylserine—SMPD4—female reproductive system—skin cancer	0.0127	0.0204	CbGeAlD
Phosphatidylserine—DGKG—head—skin cancer	0.0124	0.0199	CbGeAlD
Phosphatidylserine—PTDSS2—mammalian vulva—skin cancer	0.0121	0.0194	CbGeAlD
Phosphatidylserine—SCARB1—mammalian vulva—skin cancer	0.0118	0.019	CbGeAlD
Phosphatidylserine—SMPD3—head—skin cancer	0.0116	0.0186	CbGeAlD
Phosphatidylserine—ATP8A1—head—skin cancer	0.0114	0.0183	CbGeAlD
Phosphatidylserine—DGKD—mammalian vulva—skin cancer	0.0112	0.0179	CbGeAlD
Phosphatidylserine—PRKCA—neck—skin cancer	0.0111	0.0177	CbGeAlD
Phosphatidylserine—PISD—mammalian vulva—skin cancer	0.011	0.0176	CbGeAlD
Phosphatidylserine—PTDSS1—head—skin cancer	0.011	0.0176	CbGeAlD
Phosphatidylserine—SMPD4—head—skin cancer	0.0106	0.017	CbGeAlD
Phosphatidylserine—SCARB1—lymphoid tissue—skin cancer	0.0105	0.0169	CbGeAlD
Phosphatidylserine—PTDSS2—female reproductive system—skin cancer	0.0103	0.0166	CbGeAlD
Phosphatidylserine—SCARB1—female reproductive system—skin cancer	0.0101	0.0163	CbGeAlD
Phosphatidylserine—DGKD—female reproductive system—skin cancer	0.00955	0.0153	CbGeAlD
Phosphatidylserine—PISD—female reproductive system—skin cancer	0.00941	0.0151	CbGeAlD
Phosphatidylserine—DGKG—lymph node—skin cancer	0.00867	0.0139	CbGeAlD
Phosphatidylserine—PTDSS2—head—skin cancer	0.00863	0.0138	CbGeAlD
Phosphatidylserine—SCARB1—head—skin cancer	0.00847	0.0136	CbGeAlD
Phosphatidylserine—SMPD3—lymph node—skin cancer	0.00813	0.013	CbGeAlD
Phosphatidylserine—DGKD—head—skin cancer	0.00798	0.0128	CbGeAlD
Phosphatidylserine—ATP8A1—lymph node—skin cancer	0.00797	0.0128	CbGeAlD
Phosphatidylserine—PRKCA—connective tissue—skin cancer	0.00792	0.0127	CbGeAlD
Phosphatidylserine—PISD—head—skin cancer	0.00786	0.0126	CbGeAlD
Phosphatidylserine—PRKCA—epithelium—skin cancer	0.00752	0.0121	CbGeAlD
Phosphatidylserine—SMPD4—lymph node—skin cancer	0.00743	0.0119	CbGeAlD
Phosphatidylserine—PRKCA—skin of body—skin cancer	0.00715	0.0115	CbGeAlD
Phosphatidylserine—PTDSS2—lymph node—skin cancer	0.00604	0.00969	CbGeAlD
Phosphatidylserine—SCARB1—lymph node—skin cancer	0.00593	0.00952	CbGeAlD
Phosphatidylserine—PRKCA—lymphoid tissue—skin cancer	0.00579	0.0093	CbGeAlD
Phosphatidylserine—DGKD—lymph node—skin cancer	0.00559	0.00897	CbGeAlD
Phosphatidylserine—PRKCA—female reproductive system—skin cancer	0.00559	0.00897	CbGeAlD
Phosphatidylserine—PISD—lymph node—skin cancer	0.0055	0.00883	CbGeAlD
Phosphatidylserine—PRKCA—head—skin cancer	0.00467	0.00749	CbGeAlD
Phosphatidylserine—PRKCA—lymph node—skin cancer	0.00327	0.00525	CbGeAlD
Phosphatidylserine—PRKCA—Signaling events regulated by Ret tyrosine kinase—HRAS—skin cancer	0.000847	0.00225	CbGpPWpGaD
Phosphatidylserine—SCARB1—Metabolism—ENO2—skin cancer	0.000841	0.00223	CbGpPWpGaD
Phosphatidylserine—PRKCA—ErbB1 downstream signaling—BRAF—skin cancer	0.000834	0.00221	CbGpPWpGaD
Phosphatidylserine—DGKD—Signaling Pathways—PTCH1—skin cancer	0.00081	0.00215	CbGpPWpGaD
Phosphatidylserine—DGKD—Signaling Pathways—SMO—skin cancer	0.00081	0.00215	CbGpPWpGaD
Phosphatidylserine—DGKG—Signaling Pathways—SMO—skin cancer	0.00081	0.00215	CbGpPWpGaD
Phosphatidylserine—DGKG—Signaling Pathways—PTCH1—skin cancer	0.00081	0.00215	CbGpPWpGaD
Phosphatidylserine—DGKD—Signaling Pathways—PTGER4—skin cancer	0.000788	0.00209	CbGpPWpGaD
Phosphatidylserine—DGKG—Signaling Pathways—PTGER4—skin cancer	0.000788	0.00209	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—TLR7—skin cancer	0.000783	0.00208	CbGpPWpGaD
Phosphatidylserine—SMPD4—Metabolism—ERCC2—skin cancer	0.000783	0.00208	CbGpPWpGaD
Phosphatidylserine—PRKCA—TCR signaling in naïve CD8+ T cells—KRAS—skin cancer	0.000779	0.00207	CbGpPWpGaD
Phosphatidylserine—PRKCA—ErbB Signaling Pathway—KRAS—skin cancer	0.000768	0.00204	CbGpPWpGaD
Phosphatidylserine—PRKCA—mTOR signaling pathway—NRAS—skin cancer	0.00076	0.00202	CbGpPWpGaD
Phosphatidylserine—PRKCA—TCR signaling in naïve CD4+ T cells—NRAS—skin cancer	0.00076	0.00202	CbGpPWpGaD
Phosphatidylserine—PRKCA—Downstream signaling in naïve CD8+ T cells—NRAS—skin cancer	0.00076	0.00202	CbGpPWpGaD
Phosphatidylserine—PRKCA—a6b1 and a6b4 Integrin signaling—HRAS—skin cancer	0.000755	0.002	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—RHOU—skin cancer	0.000741	0.00197	CbGpPWpGaD
Phosphatidylserine—PRKCA—PDGFR-beta signaling pathway—BRAF—skin cancer	0.000725	0.00192	CbGpPWpGaD
Phosphatidylserine—SMPD3—Metabolism—ERCC2—skin cancer	0.000716	0.0019	CbGpPWpGaD
Phosphatidylserine—PTDSS2—Metabolism—ERCC2—skin cancer	0.000716	0.0019	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by NGF—FOXO4—skin cancer	0.000707	0.00188	CbGpPWpGaD
Phosphatidylserine—DGKG—Signaling Pathways—FOXO4—skin cancer	0.000696	0.00185	CbGpPWpGaD
Phosphatidylserine—DGKD—Signaling Pathways—FOXO4—skin cancer	0.000696	0.00185	CbGpPWpGaD
Phosphatidylserine—DGKD—Hemostasis—NRAS—skin cancer	0.000683	0.00181	CbGpPWpGaD
Phosphatidylserine—DGKG—Hemostasis—NRAS—skin cancer	0.000683	0.00181	CbGpPWpGaD
Phosphatidylserine—PRKCA—ErbB Signaling Pathway—TP53—skin cancer	0.000682	0.00181	CbGpPWpGaD
Phosphatidylserine—PISD—Metabolism—ERCC2—skin cancer	0.000666	0.00177	CbGpPWpGaD
Phosphatidylserine—PTDSS1—Metabolism—ERCC2—skin cancer	0.000666	0.00177	CbGpPWpGaD
Phosphatidylserine—PRKCA—TCR signaling in naïve CD8+ T cells—HRAS—skin cancer	0.000662	0.00176	CbGpPWpGaD
Phosphatidylserine—PRKCA—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—skin cancer	0.000662	0.00176	CbGpPWpGaD
Phosphatidylserine—PRKCA—Oncostatin M Signaling Pathway—KRAS—skin cancer	0.000662	0.00176	CbGpPWpGaD
Phosphatidylserine—SCARB1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	0.000658	0.00175	CbGpPWpGaD
Phosphatidylserine—PRKCA—Downstream signaling in naïve CD8+ T cells—KRAS—skin cancer	0.000654	0.00174	CbGpPWpGaD
Phosphatidylserine—PRKCA—TCR signaling in naïve CD4+ T cells—KRAS—skin cancer	0.000654	0.00174	CbGpPWpGaD
Phosphatidylserine—PRKCA—mTOR signaling pathway—KRAS—skin cancer	0.000654	0.00174	CbGpPWpGaD
Phosphatidylserine—PRKCA—ErbB Signaling Pathway—HRAS—skin cancer	0.000653	0.00173	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways in Glioblastoma—NRAS—skin cancer	0.000639	0.00169	CbGpPWpGaD
Phosphatidylserine—PRKCA—Spinal Cord Injury—PTGS2—skin cancer	0.000613	0.00163	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—PTCH2—skin cancer	0.000612	0.00162	CbGpPWpGaD
Phosphatidylserine—PRKCA—Kit receptor signaling pathway—HRAS—skin cancer	0.000608	0.00161	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by FGFR—BRAF—skin cancer	0.000589	0.00156	CbGpPWpGaD
Phosphatidylserine—PRKCA—EGF/EGFR Signaling Pathway—BRAF—skin cancer	0.000589	0.00156	CbGpPWpGaD
Phosphatidylserine—PRKCA—Oncostatin M Signaling Pathway—TP53—skin cancer	0.000588	0.00156	CbGpPWpGaD
Phosphatidylserine—DGKD—Hemostasis—KRAS—skin cancer	0.000588	0.00156	CbGpPWpGaD
Phosphatidylserine—DGKG—Hemostasis—KRAS—skin cancer	0.000588	0.00156	CbGpPWpGaD
Phosphatidylserine—PRKCA—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	0.000584	0.00155	CbGpPWpGaD
Phosphatidylserine—PRKCA—ATF-2 transcription factor network—IL6—skin cancer	0.000582	0.00154	CbGpPWpGaD
Phosphatidylserine—PRKCA—G Protein Signaling Pathways—NRAS—skin cancer	0.000577	0.00153	CbGpPWpGaD
Phosphatidylserine—PRKCA—Endothelins—HRAS—skin cancer	0.000577	0.00153	CbGpPWpGaD
Phosphatidylserine—PRKCA—Oncostatin M Signaling Pathway—HRAS—skin cancer	0.000563	0.00149	CbGpPWpGaD
Phosphatidylserine—PRKCA—Downstream signaling in naïve CD8+ T cells—HRAS—skin cancer	0.000556	0.00147	CbGpPWpGaD
Phosphatidylserine—PRKCA—TCR signaling in naïve CD4+ T cells—HRAS—skin cancer	0.000556	0.00147	CbGpPWpGaD
Phosphatidylserine—PRKCA—mTOR signaling pathway—HRAS—skin cancer	0.000556	0.00147	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways in Glioblastoma—KRAS—skin cancer	0.00055	0.00146	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by FGFR in disease—BRAF—skin cancer	0.000549	0.00146	CbGpPWpGaD
Phosphatidylserine—PRKCA—ErbB1 downstream signaling—NRAS—skin cancer	0.000524	0.00139	CbGpPWpGaD
Phosphatidylserine—DGKD—Hemostasis—TP53—skin cancer	0.000522	0.00139	CbGpPWpGaD
Phosphatidylserine—DGKG—Hemostasis—TP53—skin cancer	0.000522	0.00139	CbGpPWpGaD
Phosphatidylserine—PRKCA—VEGFA-VEGFR2 Pathway—NRAS—skin cancer	0.000516	0.00137	CbGpPWpGaD
Phosphatidylserine—DGKD—Hemostasis—HRAS—skin cancer	0.000499	0.00133	CbGpPWpGaD
Phosphatidylserine—DGKG—Hemostasis—HRAS—skin cancer	0.000499	0.00133	CbGpPWpGaD
Phosphatidylserine—PRKCA—Transmission across Chemical Synapses—BRAF—skin cancer	0.000498	0.00132	CbGpPWpGaD
Phosphatidylserine—PRKCA—Cell Cycle—MLH1—skin cancer	0.000497	0.00132	CbGpPWpGaD
Phosphatidylserine—PRKCA—G Protein Signaling Pathways—KRAS—skin cancer	0.000497	0.00132	CbGpPWpGaD
Phosphatidylserine—SCARB1—Metabolism—ERCC2—skin cancer	0.000489	0.0013	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways in Glioblastoma—TP53—skin cancer	0.000489	0.0013	CbGpPWpGaD
Phosphatidylserine—PRKCA—GPCR downstream signaling—MC1R—skin cancer	0.000487	0.00129	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by VEGF—NRAS—skin cancer	0.000487	0.00129	CbGpPWpGaD
Phosphatidylserine—PRKCA—NGF signalling via TRKA from the plasma membrane—BRAF—skin cancer	0.000486	0.00129	CbGpPWpGaD
Phosphatidylserine—SMPD4—Metabolism—PTGS2—skin cancer	0.000469	0.00125	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways in Glioblastoma—HRAS—skin cancer	0.000467	0.00124	CbGpPWpGaD
Phosphatidylserine—DGKD—Signaling Pathways—TERT—skin cancer	0.000465	0.00123	CbGpPWpGaD
Phosphatidylserine—DGKG—Signaling Pathways—TERT—skin cancer	0.000465	0.00123	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—TLR7—skin cancer	0.000456	0.00121	CbGpPWpGaD
Phosphatidylserine—PRKCA—PDGFR-beta signaling pathway—NRAS—skin cancer	0.000456	0.00121	CbGpPWpGaD
Phosphatidylserine—PRKCA—ErbB1 downstream signaling—KRAS—skin cancer	0.000451	0.0012	CbGpPWpGaD
Phosphatidylserine—PRKCA—VEGFA-VEGFR2 Pathway—KRAS—skin cancer	0.000444	0.00118	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—MC1R—skin cancer	0.000443	0.00117	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by Wnt—TERT—skin cancer	0.000435	0.00115	CbGpPWpGaD
Phosphatidylserine—PTDSS2—Metabolism—PTGS2—skin cancer	0.000429	0.00114	CbGpPWpGaD
Phosphatidylserine—SMPD3—Metabolism—PTGS2—skin cancer	0.000429	0.00114	CbGpPWpGaD
Phosphatidylserine—PRKCA—G Protein Signaling Pathways—HRAS—skin cancer	0.000422	0.00112	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by VEGF—KRAS—skin cancer	0.000419	0.00111	CbGpPWpGaD
Phosphatidylserine—PRKCA—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	0.000417	0.00111	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by SCF-KIT—NRAS—skin cancer	0.000414	0.0011	CbGpPWpGaD
Phosphatidylserine—PRKCA—Wnt Signaling Pathway and Pluripotency—TP53—skin cancer	0.00041	0.00109	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—PLIN2—skin cancer	0.000407	0.00108	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—FOXO4—skin cancer	0.000403	0.00107	CbGpPWpGaD
Phosphatidylserine—PTDSS1—Metabolism—PTGS2—skin cancer	0.000399	0.00106	CbGpPWpGaD
Phosphatidylserine—PISD—Metabolism—PTGS2—skin cancer	0.000399	0.00106	CbGpPWpGaD
Phosphatidylserine—PRKCA—Downstream signaling of activated FGFR—NRAS—skin cancer	0.000396	0.00105	CbGpPWpGaD
Phosphatidylserine—PRKCA—PDGFR-beta signaling pathway—KRAS—skin cancer	0.000392	0.00104	CbGpPWpGaD
Phosphatidylserine—DGKD—Signaling by GPCR—NRAS—skin cancer	0.000392	0.00104	CbGpPWpGaD
Phosphatidylserine—DGKG—Signaling by GPCR—NRAS—skin cancer	0.000392	0.00104	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—CSPG4—skin cancer	0.000391	0.00104	CbGpPWpGaD
Phosphatidylserine—PRKCA—ErbB1 downstream signaling—HRAS—skin cancer	0.000383	0.00102	CbGpPWpGaD
Phosphatidylserine—PRKCA—Neuronal System—BRAF—skin cancer	0.000382	0.00101	CbGpPWpGaD
Phosphatidylserine—PRKCA—VEGFA-VEGFR2 Pathway—HRAS—skin cancer	0.000378	0.001	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by NGF—BRAF—skin cancer	0.000374	0.000993	CbGpPWpGaD
Phosphatidylserine—PRKCA—Downstream signal transduction—NRAS—skin cancer	0.000372	0.000988	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by FGFR—NRAS—skin cancer	0.00037	0.000983	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by ERBB2—NRAS—skin cancer	0.000369	0.000978	CbGpPWpGaD
Phosphatidylserine—DGKD—Signaling Pathways—BRAF—skin cancer	0.000368	0.000977	CbGpPWpGaD
Phosphatidylserine—DGKG—Signaling Pathways—BRAF—skin cancer	0.000368	0.000977	CbGpPWpGaD
Phosphatidylserine—PRKCA—DAP12 signaling—NRAS—skin cancer	0.000367	0.000973	CbGpPWpGaD
Phosphatidylserine—PRKCA—Spinal Cord Injury—TP53—skin cancer	0.000365	0.000969	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—PTCH2—skin cancer	0.000362	0.00096	CbGpPWpGaD
Phosphatidylserine—PRKCA—VEGFA-VEGFR2 Pathway—IL6—skin cancer	0.000361	0.000959	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by VEGF—HRAS—skin cancer	0.000356	0.000946	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by SCF-KIT—KRAS—skin cancer	0.000356	0.000945	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by FGFR in disease—NRAS—skin cancer	0.000345	0.000916	CbGpPWpGaD
Phosphatidylserine—PRKCA—DAP12 interactions—NRAS—skin cancer	0.000345	0.000916	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by EGFR—NRAS—skin cancer	0.000342	0.000907	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by VEGF—IL6—skin cancer	0.000341	0.000905	CbGpPWpGaD
Phosphatidylserine—PRKCA—Downstream signaling of activated FGFR—KRAS—skin cancer	0.000341	0.000904	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by EGFR in Cancer—NRAS—skin cancer	0.000339	0.000899	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by PDGF—NRAS—skin cancer	0.000337	0.000895	CbGpPWpGaD
Phosphatidylserine—DGKD—Signaling by GPCR—KRAS—skin cancer	0.000337	0.000895	CbGpPWpGaD
Phosphatidylserine—DGKG—Signaling by GPCR—KRAS—skin cancer	0.000337	0.000895	CbGpPWpGaD
Phosphatidylserine—PRKCA—Spinal Cord Injury—IL6—skin cancer	0.000334	0.000887	CbGpPWpGaD
Phosphatidylserine—PRKCA—PDGFR-beta signaling pathway—HRAS—skin cancer	0.000333	0.000885	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—CSPG4—skin cancer	0.000328	0.00087	CbGpPWpGaD
Phosphatidylserine—PRKCA—GPCR downstream signaling—PTGER4—skin cancer	0.000321	0.000851	CbGpPWpGaD
Phosphatidylserine—PRKCA—Downstream signal transduction—KRAS—skin cancer	0.00032	0.00085	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by FGFR—KRAS—skin cancer	0.000319	0.000846	CbGpPWpGaD
Phosphatidylserine—PRKCA—EGF/EGFR Signaling Pathway—KRAS—skin cancer	0.000319	0.000846	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by ERBB2—KRAS—skin cancer	0.000317	0.000842	CbGpPWpGaD
Phosphatidylserine—PRKCA—DAP12 signaling—KRAS—skin cancer	0.000316	0.000838	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—SHH—skin cancer	0.000315	0.000837	CbGpPWpGaD
Phosphatidylserine—PRKCA—NGF signalling via TRKA from the plasma membrane—NRAS—skin cancer	0.000306	0.000811	CbGpPWpGaD
Phosphatidylserine—PRKCA—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—skin cancer	0.000305	0.000808	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by SCF-KIT—HRAS—skin cancer	0.000303	0.000804	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—PTCH1—skin cancer	0.000299	0.000793	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—SMO—skin cancer	0.000299	0.000793	CbGpPWpGaD
Phosphatidylserine—PRKCA—DAP12 interactions—KRAS—skin cancer	0.000297	0.000788	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by FGFR in disease—KRAS—skin cancer	0.000297	0.000788	CbGpPWpGaD
Phosphatidylserine—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—skin cancer	0.000295	0.000784	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by EGFR—KRAS—skin cancer	0.000294	0.000781	CbGpPWpGaD
Phosphatidylserine—SCARB1—Metabolism—PTGS2—skin cancer	0.000293	0.000777	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by EGFR in Cancer—KRAS—skin cancer	0.000292	0.000774	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—PTGER4—skin cancer	0.000291	0.000772	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by PDGF—KRAS—skin cancer	0.00029	0.000771	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by SCF-KIT—IL6—skin cancer	0.00029	0.000769	CbGpPWpGaD
Phosphatidylserine—PRKCA—Downstream signaling of activated FGFR—HRAS—skin cancer	0.00029	0.000769	CbGpPWpGaD
Phosphatidylserine—DGKD—Signaling by GPCR—HRAS—skin cancer	0.000287	0.000761	CbGpPWpGaD
Phosphatidylserine—DGKG—Signaling by GPCR—HRAS—skin cancer	0.000287	0.000761	CbGpPWpGaD
Phosphatidylserine—PRKCA—Cell Cycle, Mitotic—CDK4—skin cancer	0.000283	0.00075	CbGpPWpGaD
Phosphatidylserine—PRKCA—Cell Cycle—TERT—skin cancer	0.000282	0.000749	CbGpPWpGaD
Phosphatidylserine—PRKCA—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	0.000279	0.000742	CbGpPWpGaD
Phosphatidylserine—PRKCA—Downstream signaling of activated FGFR—IL6—skin cancer	0.000277	0.000736	CbGpPWpGaD
Phosphatidylserine—DGKD—Signaling by GPCR—IL6—skin cancer	0.000274	0.000728	CbGpPWpGaD
Phosphatidylserine—DGKG—Signaling by GPCR—IL6—skin cancer	0.000274	0.000728	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—GLI2—skin cancer	0.000274	0.000727	CbGpPWpGaD
Phosphatidylserine—PRKCA—Insulin Signaling—HRAS—skin cancer	0.000274	0.000726	CbGpPWpGaD
Phosphatidylserine—PRKCA—Downstream signal transduction—HRAS—skin cancer	0.000272	0.000723	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by FGFR—HRAS—skin cancer	0.000271	0.000719	CbGpPWpGaD
Phosphatidylserine—PRKCA—EGF/EGFR Signaling Pathway—HRAS—skin cancer	0.000271	0.000719	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by ERBB2—HRAS—skin cancer	0.00027	0.000716	CbGpPWpGaD
Phosphatidylserine—PRKCA—Myometrial Relaxation and Contraction Pathways—IL6—skin cancer	0.000269	0.000713	CbGpPWpGaD
Phosphatidylserine—PRKCA—DAP12 signaling—HRAS—skin cancer	0.000268	0.000712	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—ENO2—skin cancer	0.000266	0.000706	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—SHH—skin cancer	0.000266	0.000706	CbGpPWpGaD
Phosphatidylserine—PRKCA—NGF signalling via TRKA from the plasma membrane—KRAS—skin cancer	0.000263	0.000698	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—MC1R—skin cancer	0.000261	0.000694	CbGpPWpGaD
Phosphatidylserine—PRKCA—Downstream signal transduction—IL6—skin cancer	0.000261	0.000692	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by FGFR—IL6—skin cancer	0.000259	0.000688	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by ERBB2—IL6—skin cancer	0.000258	0.000685	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—GLI1—skin cancer	0.000258	0.000684	CbGpPWpGaD
Phosphatidylserine—PRKCA—DAP12 signaling—IL6—skin cancer	0.000257	0.000681	CbGpPWpGaD
Phosphatidylserine—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—skin cancer	0.000254	0.000675	CbGpPWpGaD
Phosphatidylserine—PRKCA—Cell Cycle—CDK4—skin cancer	0.000253	0.000671	CbGpPWpGaD
Phosphatidylserine—PRKCA—DAP12 interactions—HRAS—skin cancer	0.000252	0.00067	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by FGFR in disease—HRAS—skin cancer	0.000252	0.00067	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by EGFR—HRAS—skin cancer	0.00025	0.000664	CbGpPWpGaD
Phosphatidylserine—PRKCA—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	0.000248	0.000659	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by EGFR in Cancer—HRAS—skin cancer	0.000248	0.000658	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by PDGF—HRAS—skin cancer	0.000247	0.000655	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—SUFU—skin cancer	0.000244	0.000648	CbGpPWpGaD
Phosphatidylserine—PRKCA—DAP12 interactions—IL6—skin cancer	0.000242	0.000641	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by FGFR in disease—IL6—skin cancer	0.000242	0.000641	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by EGFR—IL6—skin cancer	0.000239	0.000635	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by EGFR in Cancer—IL6—skin cancer	0.000237	0.00063	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by PDGF—IL6—skin cancer	0.000236	0.000627	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by NGF—NRAS—skin cancer	0.000235	0.000624	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—FOXO4—skin cancer	0.000235	0.000623	CbGpPWpGaD
Phosphatidylserine—DGKD—Signaling Pathways—NRAS—skin cancer	0.000231	0.000614	CbGpPWpGaD
Phosphatidylserine—DGKG—Signaling Pathways—NRAS—skin cancer	0.000231	0.000614	CbGpPWpGaD
Phosphatidylserine—PRKCA—Transmission across Chemical Synapses—HRAS—skin cancer	0.000229	0.000608	CbGpPWpGaD
Phosphatidylserine—PRKCA—NGF signalling via TRKA from the plasma membrane—HRAS—skin cancer	0.000224	0.000593	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—ENO2—skin cancer	0.000223	0.000591	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—FOXO4—skin cancer	0.000217	0.000576	CbGpPWpGaD
Phosphatidylserine—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	0.000216	0.000573	CbGpPWpGaD
Phosphatidylserine—PRKCA—Cell Cycle, Mitotic—CDKN2A—skin cancer	0.000216	0.000573	CbGpPWpGaD
Phosphatidylserine—PRKCA—NGF signalling via TRKA from the plasma membrane—IL6—skin cancer	0.000214	0.000568	CbGpPWpGaD
Phosphatidylserine—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	0.000207	0.000549	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by NGF—KRAS—skin cancer	0.000202	0.000537	CbGpPWpGaD
Phosphatidylserine—DGKG—Signaling Pathways—KRAS—skin cancer	0.000199	0.000529	CbGpPWpGaD
Phosphatidylserine—DGKD—Signaling Pathways—KRAS—skin cancer	0.000199	0.000529	CbGpPWpGaD
Phosphatidylserine—PRKCA—Cell Cycle—CDKN2A—skin cancer	0.000193	0.000513	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—SHH—skin cancer	0.000186	0.000494	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—RASA1—skin cancer	0.000185	0.000491	CbGpPWpGaD
Phosphatidylserine—DGKG—Signaling Pathways—TP53—skin cancer	0.000177	0.00047	CbGpPWpGaD
Phosphatidylserine—DGKD—Signaling Pathways—TP53—skin cancer	0.000177	0.00047	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—PTCH1—skin cancer	0.000177	0.000469	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—SMO—skin cancer	0.000177	0.000469	CbGpPWpGaD
Phosphatidylserine—PRKCA—Neuronal System—HRAS—skin cancer	0.000175	0.000465	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by NGF—HRAS—skin cancer	0.000172	0.000456	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—PTGER4—skin cancer	0.000172	0.000456	CbGpPWpGaD
Phosphatidylserine—DGKD—Signaling Pathways—HRAS—skin cancer	0.000169	0.000449	CbGpPWpGaD
Phosphatidylserine—DGKG—Signaling Pathways—HRAS—skin cancer	0.000169	0.000449	CbGpPWpGaD
Phosphatidylserine—PRKCA—Gene Expression—ERCC2—skin cancer	0.000166	0.000442	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by NGF—IL6—skin cancer	0.000165	0.000437	CbGpPWpGaD
Phosphatidylserine—DGKD—Signaling Pathways—IL6—skin cancer	0.000162	0.00043	CbGpPWpGaD
Phosphatidylserine—DGKG—Signaling Pathways—IL6—skin cancer	0.000162	0.00043	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—ERCC2—skin cancer	0.000155	0.00041	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—FOXO4—skin cancer	0.000152	0.000403	CbGpPWpGaD
Phosphatidylserine—PRKCA—Hemostasis—NRAS—skin cancer	0.000149	0.000395	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—TERT—skin cancer	0.000145	0.000384	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—NRAS—skin cancer	0.000134	0.000356	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—ERCC2—skin cancer	0.000129	0.000343	CbGpPWpGaD
Phosphatidylserine—PRKCA—Hemostasis—KRAS—skin cancer	0.000128	0.00034	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—KRAS—skin cancer	0.000115	0.000306	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—BRAF—skin cancer	0.000115	0.000304	CbGpPWpGaD
Phosphatidylserine—PRKCA—Hemostasis—TP53—skin cancer	0.000114	0.000302	CbGpPWpGaD
Phosphatidylserine—PRKCA—Hemostasis—HRAS—skin cancer	0.000109	0.000289	CbGpPWpGaD
Phosphatidylserine—PRKCA—Cell Cycle—TP53—skin cancer	0.000108	0.000285	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—TERT—skin cancer	0.000101	0.000269	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—HRAS—skin cancer	9.81e-05	0.00026	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—IL6—skin cancer	9.39e-05	0.000249	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—PTGS2—skin cancer	9.27e-05	0.000246	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—NRAS—skin cancer	8.55e-05	0.000227	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—BRAF—skin cancer	8.03e-05	0.000213	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—NRAS—skin cancer	7.81e-05	0.000207	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—PTGS2—skin cancer	7.76e-05	0.000206	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—KRAS—skin cancer	7.36e-05	0.000195	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—NRAS—skin cancer	7.21e-05	0.000191	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—KRAS—skin cancer	6.72e-05	0.000178	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—HRAS—skin cancer	6.25e-05	0.000166	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—KRAS—skin cancer	6.21e-05	0.000165	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—IL6—skin cancer	5.98e-05	0.000159	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—HRAS—skin cancer	5.71e-05	0.000152	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—IL6—skin cancer	5.47e-05	0.000145	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—HRAS—skin cancer	5.27e-05	0.00014	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—NRAS—skin cancer	5.05e-05	0.000134	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—IL6—skin cancer	5.05e-05	0.000134	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—KRAS—skin cancer	4.35e-05	0.000115	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—TP53—skin cancer	3.86e-05	0.000102	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—HRAS—skin cancer	3.69e-05	9.8e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—IL6—skin cancer	3.54e-05	9.38e-05	CbGpPWpGaD
